Turning point in COVID-19 severity and fatality during the pandemic: a national cohort study in Qatar

Type: Article

Publication Date: 2023-10-01

Citations: 6

DOI: https://doi.org/10.1136/bmjph-2023-000479

Abstract

Objective To assess the evolution of COVID-19 severity and fatality in a unique setting that consistently applied, throughout the pandemic, rigorous and standardised criteria for defining severe COVID-19 outcomes. Methods and analysis We conducted a national cohort study on 312 109 Qatari citizens to investigate incidence of severe, critical or fatal COVID-19 classified according to the WHO criteria between 28 February 2020 and 21 April 2023. Incidence rates for severe, critical or fatal COVID-19 were estimated during the pre-omicron phase, first omicron wave, combined phases and throughout the pandemic. Results Cumulative incidence of severe, critical or fatal COVID-19 after 3.14 years of follow-up was 0.45% (95% CI 0.43% to 0.47%). Incidence rate for severe, critical or fatal COVID-19 throughout the pandemic was 1.43 (95% CI 1.35 to 1.50) per 1000 person years. In the pre-omicron phase, first omicron wave, and combined phases, it was 2.01 (95% CI 1.90 to 2.13), 3.70 (95% CI 3.25 to 4.22) and 2.18 (95% CI 2.07 to 2.30) per 1000 person years, respectively. The post-first omicron phase saw a drastic drop to 0.10 (95% CI 0.08 to 0.14) per 1000 person years, a 95.4% reduction. Among all severe, critical and fatal cases, 99.5% occurred during the primary infection. Cumulative incidence of fatal COVID-19 was 0.042% (95% CI 0.036% to 0.050%), with an incidence rate of 0.13 (95% CI 0.11 to 0.16) per 1000 person years. In the post-first omicron phase, incidence rate of fatal COVID-19 decreased by 90.0% compared with earlier stages. Both severity and fatality exhibited an exponential increase with age and a linear increase with the number of coexisting conditions. Conclusion The conclusion of the first omicron wave was a turning point in the severity of the pandemic. While vaccination and enhanced case management reduced severity gradually, the rapid accumulation of natural immunity during the first omicron wave appears to have played a critical role in driving this shift in severity.

Locations

  • medRxiv (Cold Spring Harbor Laboratory) - View
  • BMJ Public Health - View - PDF

Similar Works

Action Title Year Authors
+ PDF Chat A turning point in COVID-19 severity and fatality during the pandemic: A national cohort study in Qatar 2023 Hiam Chemaitelly
Houssein H. Ayoub
Jeremy Samuel Faust
Peter Coyle
Patrick Tang
Mohammad R. Hasan
Hadi M. Yassine
Hebah A. Al-Khatib
Asmaa A. Al Thani
Zaina Al Kanaani
+ PDF Chat Epidemiological investigation of the first 5685 cases of SARS-CoV-2 infection in Qatar, 28 February–18 April 2020 2020 Hanan M Al Kuwari
Hanan F. Abdul Rahim
Laith J. Abu‐Raddad
Abdul‐Badi Abou‐Samra
Zaina Al Kanaani
Abdullatif Al Khal
Einas Al Kuwari
Salih Al Marri
Muna Al Masalmani
Hamad Eid Al‐Romaihi
+ SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar 2021 Shaheen Seedat
Hiam Chemaitelly
Houssein H. Ayoub
Monia Makhoul
Ghina R. Mumtaz
Zaina Al Kanaani
Abdullatif Al Khal
Einas Al Kuwari
Adeel A. Butt
Peter Coyle
+ PDF Chat Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study 2023 Hiam Chemaitelly
Jeremy Samuel Faust
Harlan M. Krumholz
Houssein H. Ayoub
Patrick Tang
Peter Coyle
Hadi M. Yassine
Asmaa A. Al Thani
Hebah A. Al-Khatib
Mohammad R. Hasan
+ Characterization of the SARS-CoV-2 outbreak in the State of Qatar, February 28-April 18, 2020 2020 Hanan M Al Kuwari
Hanan F. Abdul Rahim
Laith J. Abu‐Raddad
Abdul‐Badi Abou‐Samra
Zaina Al Kanaani
Abdullatif Al Khal
Einas Al Kuwari
Salih Al Marri
Muna Al Masalmani
Hamad Eid Al‐Romaihi
+ PDF Chat Seroprevalence of SARS-Cov2 in Qatar: A Longitudinal Epidemiological study 2020 Farah M. Shurrab
Hadeel Al-Jighefee
Salma Younes
Duaa W. Al‐Sadeq
Asmaa Althani
Hadi Yassine
Mohamed Ahmed Syed
Ahmed AlNuami
Hamda Qotba
Gheyath K. Nasrallah
+ Understanding the epidemiological characteristics of the primary healthcare corporation-based COVID-19 swabbed persons in Qatar, 2020 2022 Mariam Abdulmalik
Mohamed Ghaith Al‐Kuwari
Ahmad Haj Bakri
Samya Al Abdulla
Mujeeb Chettiyam Kandy
Maha Yousef Abdulla
John Gibb
+ The epidemiological characteristics of the primary health care based COVID-19 swabbed persons in Qatar, March- October 2020 2021 Mohamed Ghaith Al‐Kuwari
Mariam Abdulmalik
Ahmad Haj Bakri
Mujeeb Chettiyam Kandy
Maha Youssef Abdulla
John Gibb
+ PDF Chat All-cause and COVID-19 mortality in Qatar during the COVID-19 pandemic 2023 Asma Ali Al-Nuaimi
Hiam Chemaitelly
Sandy Semaan
Sawsan AlMukdad
Zaina Al Kanaani
Anvar Hassan Kaleeckal
Ali Nizar Latif
Hamad Eid Al‐Romaihi
Adeel A. Butt
Mohamed H. Al‐Thani
+ PDF Chat 2288. Short and Longer-Term All-Cause Mortality among SARS CoV-2-Infected Persons and the Pull-Forward Phenomenon in Qatar 2023 Hiam Chemaitelly
Jeremy Samuel Faust
Harlan M. Krumholz
Houssein H. Ayoub
Laith J. Abu‐Raddad
+ SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates 2020 Shaheen Seedat
Hiam Chemaitelly
Houssein H. Ayoub
Monia Makhoul
Ghina R. Mumtaz
Zaina Al Kanaani
Abdullatif Al Khal
Einas Al Kuwari
Adeel A. Butt
Peter Coyle
+ Studying Disease Reinfection Rates, Vaccine Efficacy and the Timing of Vaccine Rollout in the context of Infectious Diseases 2023 Elizabeth Amona
Indranil Sahoo
Edward L. Boone
Ryad Ghanam
+ PDF Chat Short- and longer-term all-cause mortality among SARS-CoV-2-infected persons and the pull-forward phenomenon in Qatar 2023 Hiam Chemaitelly
Jeremy Samuel Faust
Harlan M. Krumholz
Houssein H. Ayoub
Patrick Tang
Peter Coyle
Hadi M. Yassine
Asmaa A. Al Thani
Hebah A. Al-Khatib
Mohammad R. Hasan
+ PDF Chat Risk factors for severe Covid-19 breakthrough infections: an observational longitudinal study 2022 Sihem Ben Fredj
Rim Ghammem
Nawel Zammit
A Maatouk
Nihel Haddad
Nouha Haddad
Manel Kachroudi
Senda Rebai
Hafsia Laadhari
Mohamed Mizouni Ghodhbani
+ PDF Chat The Epidemiological Pattern of COVID-19 Epidemic, During the Initial Phase in Thi-Qar Governorate, Iraq: A Case Series Study 2020 Muslim Musa
+ Severity, criticality, and fatality of the SARS-CoV-2 Beta variant 2021 Laith J. Abu‐Raddad
Hiam Chemaitelly
Houssein H. Ayoub
Hadi M. Yassine
Fatiha M. Benslimane
Hebah A. Al-Khatib
Patrick Tang
Mohammad R. Hasan
Peter Coyle
Sawsan AlMukdad
+ PDF Chat The real COVID-19 pandemic dynamics in Qatar in 2021: simulations, predictions and verifications of the SIR model 2021 Igor Nesteruk
+ PDF Chat Key Lessons from COVID-19: A Narrative Review Describing Qatar’s Multifactorial Approach in Executing a Vaccination Campaign 2023 Soha Shawqi Albayat
Muna Almaslamani
Hamad Eid Al‐Romaihi
Hayat Khogali
Jesha Mundodan
Jean Joury
Hammam Haridy
+ Impact of vaccination and undetected cases on the COVID-19 pandemic dynamics in Qatar in 2021 2021 Igor Nesteruk
+ Pre-symptomatic and asymptomatic transmission of COVID-19: Implications for control measures in Qatar 2021 Abdelaziz M Tawengi
Samantha Johnston
Soha Shawqi Albayat
Devendra Bansal
Shazia Ahmed
Mohamed Sallam
Hamad Eid Al‐Romaihi
Mohammed Al‐Thani
Elmoubasher Farag
Mohamed M. Emara

Works Cited by This (15)

Action Title Year Authors
+ A Review on Smoothing Methods for the Estimation of the Hazard Rate Based on Kernel Functions 1992 Olaf Gefeller
Peter Michels
+ Nonparametric Estimation from Incomplete Observations 1958 Edward L. Kaplan
Paul Meier
+ Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar 2021 Andrew Jeremijenko
Hiam Chemaitelly
Houssein H. Ayoub
Moza Alishaq
Abdul‐Badi Abou‐Samra
Jameela Ali Al Ajmi
Nasser Ansari
Zaina Al Kanaani
Abdullatif Al Khal
Einas Al Kuwari
+ PDF Chat SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar 2021 Mohamed H. Al‐Thani
Elmoubasher Farag
Roberto Bertollini
Hamad Eid Al‐Romaihi
Sami Abdeen
Ashraf Abdelkarim
Faisal Daraan
Ahmed Ismail
Nahid Mostafa
Mohamed Sahl
+ SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar 2021 Shaheen Seedat
Hiam Chemaitelly
Houssein H. Ayoub
Monia Makhoul
Ghina R. Mumtaz
Zaina Al Kanaani
Abdullatif Al Khal
Einas Al Kuwari
Adeel A. Butt
Peter Coyle
+ Estimates of global SARS-CoV-2 infection exposure, infection morbidity, and infection mortality rates in 2020 2021 Houssein H. Ayoub
Ghina R. Mumtaz
Shaheen Seedat
Monia Makhoul
Hiam Chemaitelly
Laith J. Abu‐Raddad
+ SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity 2022 Stefan Pilz
Verena Theiler‐Schwetz
Christian Trummer
Robert Krause
John P. A. Ioannidis
+ PDF Chat Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21 2022 Haidong Wang
Katherine Paulson
Spencer A Pease
Stefanie Watson
Haley Comfort
Peng Zheng
Aleksandr Y. Aravkin
Catherine Bisignano
Ryan M Barber
Shazia Alam
+ PDF Chat COVID-19 Disease Severity in Persons Infected With Omicron BA.1 and BA.2 Sublineages and Association With Vaccination Status 2022 Adeel A. Butt
Soha R. Dargham
Peter Coyle
Hadi M. Yassine
Abdullatif Al‐Khal
Abdul‐Badi Abou‐Samra
Laith J. Abu‐Raddad
+ Uncoupling of all-cause excess mortality from COVID-19 cases in a highly vaccinated state 2022 Jeremy Samuel Faust
Benjamin Renton
Alexander Chen
Chengan Du
Chenxue Liang
Shu‐Xia Li
Zhenqiu Lin
Harlan M. Krumholz